| Theresa Elizabeth Mellette, DO | |
|
1320 Maplewood Ave, Ronceverte, WV 24970-8016 | |
| (304) 647-4411 | |
| Not Available |
| Full Name | Theresa Elizabeth Mellette |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 1320 Maplewood Ave, Ronceverte, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922488956 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | TRAINING (West Virginia) | Secondary |
| 207Q00000X | Family Medicine | 3100 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospicecare, Inc | Charleston, WV | Hospice |
| Greenbrier Valley Medical Center | Ronceverte, WV | Hospital |
| Charleston Area Medical Center | Charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Charleston Area Medical Center Inc | 3375441637 | 675 |
News Archive
Bristol-Myers Squibb Company today announced interim results from the expanded Phase 1 dose-ranging study 003 (n=296) of its investigational anti-PD-1 immunotherapy (BMS-936558), which showed clinical activity in patients with previously-treated non small-cell lung cancer (NSCLC), metastatic melanoma and renal cell carcinoma (RCC).
A study from the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine identifies a mechanism by which bioscaffolds used in regenerative medicine influence cellular behavior, a question that has remained unanswered since the technology was first developed several decades ago.
The tiny teeth of Australian toddlers are rotting and dental researchers at the University of Sydney are poised to start a long-term study to find out why.
Medifast, Inc., a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, announced today that Timothy Robinson, Chief Financial Officer, and Meg Sheetz, President and Chief Operating Officer, will present at the Jefferies 2014 Global Consumer Conference on Thursday, June 19, 2014 in Nantucket, MA.
› Verified 4 days ago
| Entity Name | Charleston Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124248752 PECOS PAC ID: 3375441637 Enrollment ID: O20031223000426 |
News Archive
Bristol-Myers Squibb Company today announced interim results from the expanded Phase 1 dose-ranging study 003 (n=296) of its investigational anti-PD-1 immunotherapy (BMS-936558), which showed clinical activity in patients with previously-treated non small-cell lung cancer (NSCLC), metastatic melanoma and renal cell carcinoma (RCC).
A study from the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine identifies a mechanism by which bioscaffolds used in regenerative medicine influence cellular behavior, a question that has remained unanswered since the technology was first developed several decades ago.
The tiny teeth of Australian toddlers are rotting and dental researchers at the University of Sydney are poised to start a long-term study to find out why.
Medifast, Inc., a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, announced today that Timothy Robinson, Chief Financial Officer, and Meg Sheetz, President and Chief Operating Officer, will present at the Jefferies 2014 Global Consumer Conference on Thursday, June 19, 2014 in Nantucket, MA.
› Verified 4 days ago
| Entity Name | Kanawha Hospice Care, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174556641 PECOS PAC ID: 7416973805 Enrollment ID: O20180102000674 |
News Archive
Bristol-Myers Squibb Company today announced interim results from the expanded Phase 1 dose-ranging study 003 (n=296) of its investigational anti-PD-1 immunotherapy (BMS-936558), which showed clinical activity in patients with previously-treated non small-cell lung cancer (NSCLC), metastatic melanoma and renal cell carcinoma (RCC).
A study from the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine identifies a mechanism by which bioscaffolds used in regenerative medicine influence cellular behavior, a question that has remained unanswered since the technology was first developed several decades ago.
The tiny teeth of Australian toddlers are rotting and dental researchers at the University of Sydney are poised to start a long-term study to find out why.
Medifast, Inc., a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, announced today that Timothy Robinson, Chief Financial Officer, and Meg Sheetz, President and Chief Operating Officer, will present at the Jefferies 2014 Global Consumer Conference on Thursday, June 19, 2014 in Nantucket, MA.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Elizabeth Mellette, DO 1320 Maplewood Ave, Ronceverte, WV 24970-8016 Ph: () - | Theresa Elizabeth Mellette, DO 1320 Maplewood Ave, Ronceverte, WV 24970-8016 Ph: (304) 647-4411 |
News Archive
Bristol-Myers Squibb Company today announced interim results from the expanded Phase 1 dose-ranging study 003 (n=296) of its investigational anti-PD-1 immunotherapy (BMS-936558), which showed clinical activity in patients with previously-treated non small-cell lung cancer (NSCLC), metastatic melanoma and renal cell carcinoma (RCC).
A study from the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine identifies a mechanism by which bioscaffolds used in regenerative medicine influence cellular behavior, a question that has remained unanswered since the technology was first developed several decades ago.
The tiny teeth of Australian toddlers are rotting and dental researchers at the University of Sydney are poised to start a long-term study to find out why.
Medifast, Inc., a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, announced today that Timothy Robinson, Chief Financial Officer, and Meg Sheetz, President and Chief Operating Officer, will present at the Jefferies 2014 Global Consumer Conference on Thursday, June 19, 2014 in Nantucket, MA.
› Verified 4 days ago
Dr. Constance L. Anderson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1320 Maplewood Ave Ste A, Ronceverte, WV 24970 Phone: 304-647-5114 | |
Dr. Debra R Crites-sams, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1478 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-645-4406 Fax: 304-645-4492 | |
Carolyn Bridgett Morrison, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1320 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-645-1787 | |
Dr. Jessica Sue Aliff, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-647-6529 | |
Leslie Abigail Winters, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 202 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-793-2274 Fax: 304-793-2275 | |
Mrs. Jamie Louise Vance, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1322 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-647-1139 Fax: 304-647-3006 | |
Joshua Paul Ennis, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1320 Maplewood Ave, Ronceverte, WV 24970 Phone: 304-647-4411 |